Medtech giant launches attack on Ambu's future hope

One of the world's heavyweights in medical equipment has now announced itself as a player in the market for single-use equipment for duodenum examinations with the so-called duodenoscopes. A massive threat to Ambu according to analyst firm. Ambu's CEO calls it good news.

Lars Marcher, President and CEO of medtech group Ambu, welcomes the competition from Boston Scientific. Photo: /ritzau/Claus Bech

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles